- Enrollment
- 14
- Started
- Nov 2022
- Completion
- Oct 2023
- Locations
- 24
- Countries
- 6
- Updated
- Apr 2024
Industry sponsor intelligence
Invex Therapeutics Ltd.Clinical Pipeline.
Lead-sponsor view of Invex Therapeutics Ltd.'s indexed peptide studies, development phases, active programs, completed work and recent registry changes.
- Total
- 1
- Recruiting
- 0
- Active
- 0
- Completed
- 0
- Results posted
- 1
- Avg enrollment
- 14
Pipeline overview
Programs by phase and activity.
Velocity
Invex Therapeutics Ltd. trials by start year
Study start year · indexed snapshot
Development
Trials by phase
1phase labels
Early Phase 10
Phase 10
Phase 20
Phase 31
Phase 40
| Product | Studies | Early / I | Phase II | Phase III | Phase IV | Active |
|---|---|---|---|---|---|---|
| Exenatide → | 1 | 0 | 0 | 1 | 0 | 0 |
Active peptide trials
In motion now.
No studies in this snapshot.
Completed trials
Finished registry records.
No studies in this snapshot.
Search sponsor records
All Invex Therapeutics Ltd. studies.
This page groups studies where Invex Therapeutics Ltd. is listed as the lead industry sponsor. Collaborator-only records are not included in the count.
1 matching study
Last registry update first
Recent updates